RNS Number:1685Q
Celltech Group PLC
25 September 2003

                                  SCHEDULE 10

                   NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company
Celltech Group plc

2. Name of shareholder having a major interest
Franklin Resources, Inc. and its affiliates including Franklin Mutual Advisers,
LLC and Templeton Worldwide, Inc. and its affiliates

3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Bank of New York, London                            1,165,146
Bank of New York, Europe                            11,230
Chase NA London                                     10,087,113
Citibank NA London                                  39,020
Mellon Bank NA                                      542,108
Northern Trust Company                              791,505
Royal Trust Corp of Canada                          178,312
State Street Nominees Limited                       1,840,323

5. Number of shares / amount of stock acquired
803,049 since last notification

6. Percentage of issued class
0.28%

7. Number of shares / amount of stock disposed
N/a

8. Percentage of issued class
N/a

9. Class of security
Ordinary 50p shares

10. Date of transaction
Unknown

11. Date company informed
25 September 2003

12. Total holding following this notification
14,654,757

13. Total percentage holding of issued class following this notification
5.279%

14. Any additional information

15. Name of contact and telephone number for queries
Anita Dowling (01753) 777106

16. Name and signature of authorised company official responsible for making
this notification
J A D Slater

Date of notification
25 September 2003

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLEAFNSAFEDEFE